The arrival of Opill, the first over-the-counter oral contraceptive in the United States, marks a significant milestone in reproductive health accessibility. With a manufacturer’s suggested [more…]
Viking Therapeutics surged approximately 80% on Tuesday following the announcement of promising results from its mid-stage trial of an experimental weight loss drug. The drug, [more…]
Eisai plans to introduce its groundbreaking Alzheimer’s drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis [more…]
In a sobering turn of events, Japan has reported its first death from mpox, a viral disease that has been causing concern since its first [more…]
In a monumental stride forward in medical science, the U.S. Food and Drug Administration (FDA) has granted approval for the first gene-editing treatment for sickle [more…]
In a concerning turn of events, South Korea is grappling with a resurgence of highly pathogenic avian influenza (AI) as health authorities confirmed a second [more…]
In the heart of Rio de Janeiro, where the rhythms of samba once danced in harmony with a groundbreaking movement to provide affordable HIV treatment, [more…]
Japan, known for its rich history and advanced technology, is facing a daunting challenge as its population continues to gray and decline. Government data has [more…]
In a groundbreaking development, the Food and Drug Administration (FDA) has granted approval to Eli Lilly’s blockbuster drug, tirzepatide, for the treatment of obesity in [more…]
Novo Nordisk, a global pharmaceutical company known for its innovative treatments in diabetes care and obesity management, recently announced an encouraging development regarding the accessibility [more…]
